[go: up one dir, main page]

MY127144A - New anticholinergics which may be used as medicaments as well as processes for preparing them - Google Patents

New anticholinergics which may be used as medicaments as well as processes for preparing them

Info

Publication number
MY127144A
MY127144A MYPI20014765A MYPI20014765A MY127144A MY 127144 A MY127144 A MY 127144A MY PI20014765 A MYPI20014765 A MY PI20014765A MY PI20014765 A MYPI20014765 A MY PI20014765A MY 127144 A MY127144 A MY 127144A
Authority
MY
Malaysia
Prior art keywords
preparing
processes
medicaments
well
anticholinergics
Prior art date
Application number
MYPI20014765A
Inventor
Georg Speck Dr
Rolf Banholzer Dr
Richard Reichl Dr
Meissner Helmut
Morschhauser Gerd
Gerald Pohl Dr
Michael-Paul Pieper Dr
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MY127144A publication Critical patent/MY127144A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

THE PRESENT INVENTION RELATES TO NEW ANTICHOLINERGICS OF GENERAL FORMULA 1: WHEREIN A, X- AND THE GROUPS R1, R2, R3, R4, R5, R6 AND R7 MAY HAVE THE MEANINGS GIVEN IN THE CLAIMS AND IN THE SPECIFICATION, PROCESSES FOR PREPARING THEM AND THEIR USE AS PHARAMACEUTICAL COMPOSITIONS.
MYPI20014765A 2000-10-14 2001-10-12 New anticholinergics which may be used as medicaments as well as processes for preparing them MY127144A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10050994A DE10050994A1 (en) 2000-10-14 2000-10-14 New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease

Publications (1)

Publication Number Publication Date
MY127144A true MY127144A (en) 2006-11-30

Family

ID=7659808

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20014765A MY127144A (en) 2000-10-14 2001-10-12 New anticholinergics which may be used as medicaments as well as processes for preparing them

Country Status (37)

Country Link
EP (2) EP1382606A3 (en)
JP (2) JP4109106B2 (en)
KR (1) KR100830359B1 (en)
CN (1) CN1275962C (en)
AR (1) AR035589A1 (en)
AT (1) ATE259805T1 (en)
AU (2) AU1397502A (en)
BG (1) BG66225B1 (en)
BR (1) BR0114635A (en)
CA (1) CA2425557C (en)
DE (2) DE10050994A1 (en)
DK (1) DK1325001T3 (en)
EA (1) EA005816B1 (en)
EC (1) ECSP034542A (en)
EE (1) EE05179B1 (en)
ES (1) ES2215147T3 (en)
HR (1) HRP20030278B1 (en)
HU (1) HUP0301203A3 (en)
IL (2) IL155334A0 (en)
ME (1) MEP39908A (en)
MX (1) MXPA03003160A (en)
MY (1) MY127144A (en)
NO (1) NO328207B1 (en)
NZ (1) NZ525836A (en)
PE (1) PE20020433A1 (en)
PL (1) PL207311B1 (en)
PT (1) PT1325001E (en)
RS (1) RS50464B (en)
SA (1) SA01220414B1 (en)
SI (1) SI1325001T1 (en)
SK (1) SK287138B6 (en)
TR (1) TR200400376T4 (en)
TW (1) TWI306098B (en)
UA (1) UA73804C2 (en)
UY (1) UY26958A1 (en)
WO (1) WO2002032899A1 (en)
ZA (1) ZA200302914B (en)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10200943A1 (en) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Process for the preparation of scopine esters
US7405224B2 (en) 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
DE10203753A1 (en) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma New xanthene carboxylic acid esters, processes for their preparation and their use as medicines
DE10216429A1 (en) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Synergistic medicaments for treating inflammatory or obstructive respiratory tract diseases, containing quaternized scopine ester anticholinergic agent and steroid, e.g. budesonide
US7417051B2 (en) 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
DE10256317A1 (en) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt
CA2481468C (en) * 2002-04-12 2011-02-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments containing betamimetic drugs and a novel anticholinesterase drug
US7084153B2 (en) 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
DE10224091A1 (en) * 2002-05-31 2003-12-11 Boehringer Ingelheim Pharma Technical process for the production of tropenol
DE10230769A1 (en) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug compositions based on new anticholinergics and PDE-IV inhibitors
DE10230751A1 (en) 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug compositions based on new anticholinergics and EGFR kinase inhibitors
AU2003245989A1 (en) 2002-07-09 2004-01-23 Boehringer Ingelheim Pharma Gmbh And Co. Kg Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
DE10230750A1 (en) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug compositions based on new anticholonergics and NK1 receptor antagonists
EP1908468A1 (en) * 2002-08-14 2008-04-09 Boehringer Ingelheim Pharma GmbH & Co. KG Aerosol formula for inhalation containing an anticholinergic agent
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (en) * 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalable medicament for treating inflammatory or obstructive respiratory diseases, containing synergistic combination of tropane derivative anticholinergic agent, corticosteroid and beta-mimetic agent
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (en) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt
DE10323966A1 (en) * 2003-05-27 2004-12-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting drug combinations for the treatment of respiratory diseases
US7332175B2 (en) 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
US7462367B2 (en) 2003-07-11 2008-12-09 Boehringer Ingelheim International Gmbh Anticholinergic powder formulations for inhalation
DE10331350A1 (en) * 2003-07-11 2005-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalation powder useful for treating respiratory diseases comprises a 9,9-dimethyl-7-(2,2-diphenylpropionyloxy)-3-oxa-9-azatricyclononane salt and a finely divided excipient
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
JP2007500146A (en) * 2003-07-28 2007-01-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Drugs for inhalation containing beta receptor stimulants and anticholinergics
WO2005013967A1 (en) * 2003-07-28 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders
ATE435018T1 (en) * 2003-07-28 2009-07-15 Boehringer Ingelheim Int INHALATION MEDICATIONS WITH STEROIDS AND A NEW FLUORECARBOXYLIC ACID ESTER
WO2005014044A1 (en) * 2003-07-29 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising betamimetics and an anticholinergic
ATE526967T1 (en) * 2003-07-31 2011-10-15 Boehringer Ingelheim Int INHALATION MEDICATIONS CONTAINING AN ANTICHOLINERGIC AND A BETAMIMETIC
EP1504756A1 (en) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Medicament compositions comprising a heterocyclic compound and an anticholinergic
DE10345065A1 (en) 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
EP1706118A1 (en) * 2004-01-09 2006-10-04 Boehringer Ingelheim International GmbH New pharmaceutical compositions based on a scopineester and nicotinamide derivatives
US7507745B2 (en) 2004-02-20 2009-03-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
US20050186175A1 (en) * 2004-02-20 2005-08-25 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins
EP1718301A1 (en) * 2004-02-20 2006-11-08 Boehringer Ingelheim International GmbH Pharmaceutical compositions based on anticholinergics and pegsunercept
DE102004016179A1 (en) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Compounds for the treatment of proliferative processes
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE602004020337D1 (en) * 2004-08-11 2009-05-14 Boehringer Ingelheim Pharma Anticholinergic drugs for the treatment of urinary tract disorders
DE102004056578A1 (en) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhaled drugs containing a new anticholinergic, formoterol and a steroid
CA2597942A1 (en) * 2005-02-16 2006-08-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising anticholinergics and etiprednol
EP1858554A2 (en) * 2005-03-09 2007-11-28 Boehringer Ingelheim International GmbH New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
EP1893203A2 (en) * 2005-05-31 2008-03-05 Boehringer Ingelheim International GmbH Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
CA2611907A1 (en) * 2005-06-17 2006-12-21 Boehringer Ingelheim International Gmbh Mrp iv inhibitors for the treatment of respiratory diseases
DE102005030733A1 (en) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient
WO2007020227A1 (en) 2005-08-15 2007-02-22 Boehringer Ingelheim International Gmbh Method for producing betamimetics
EP1948164A1 (en) 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Pharmaceutical compositions of muscarinic receptor antagonists
DE102005055957A1 (en) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005055961A1 (en) * 2005-11-24 2007-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical composition containing specific concentration of quaternary ammonium anticholinergic agent, useful for treatment, by inhalation, of respiratory tract diseases
DE102005055963A1 (en) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE502007006951D1 (en) 2006-08-07 2011-05-26 Boehringer Ingelheim Pharma MEDICINAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
HRP20120361T1 (en) 2007-03-14 2012-05-31 Ranbaxy Laboratories Limited PYRAZOLO [3,4-b] PyRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS
EP2011538B1 (en) 2007-07-06 2016-02-17 Vectura Delivery Devices Limited Inhaler
US20100234411A1 (en) * 2007-07-18 2010-09-16 Boehringer Ingelheim Intermational Gmbh New Combination for the Treatment of Respiratory Diseases
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2082768A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082766A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Blister Strip Coil Forming
EP2082767A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082771A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082772A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP2432531B1 (en) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalation device and nebulizer
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
NZ599295A (en) 2009-11-25 2014-06-27 Boehringer Ingelheim Int Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (en) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
NZ706573A (en) 2012-12-21 2019-11-29 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
LT2934544T (en) 2012-12-21 2019-02-25 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical formulation comprising ciclesonide
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
BR112016023932B1 (en) 2014-05-07 2022-11-29 Boehringer Ingelheim International Gmbh NEBULIZER
DK3139984T3 (en) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Atomizer
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
KR102618119B1 (en) 2014-06-18 2023-12-27 베링거잉겔하임베트메디카게엠베하 Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
WO2017040764A1 (en) * 2015-09-04 2017-03-09 Janssen Pharmaceutica Nv Therapeutic compounds for pain and synthesis thereof
CN113292574B (en) * 2020-02-21 2022-05-03 四川大学 Chiral polycyclic tropane compounds, preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (en) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
BG107688A (en) 2003-09-30
EA005816B1 (en) 2005-06-30
IL155334A (en) 2009-02-11
SA01220414B1 (en) 2007-01-20
EE200300151A (en) 2003-06-16
CA2425557A1 (en) 2003-04-11
CA2425557C (en) 2007-11-13
CN1468236A (en) 2004-01-14
TR200400376T4 (en) 2004-03-22
EP1325001A1 (en) 2003-07-09
DE50101524D1 (en) 2004-03-25
SK287138B6 (en) 2010-01-07
AR035589A1 (en) 2004-06-16
NZ525836A (en) 2004-09-24
DE10050994A1 (en) 2002-04-18
WO2002032899A1 (en) 2002-04-25
SI1325001T1 (en) 2004-08-31
HRP20030278A2 (en) 2005-02-28
AU1397502A (en) 2002-04-29
CN1275962C (en) 2006-09-20
ZA200302914B (en) 2003-11-14
BR0114635A (en) 2004-02-10
MEP39908A (en) 2011-02-10
TWI306098B (en) 2009-02-11
UY26958A1 (en) 2002-06-20
ATE259805T1 (en) 2004-03-15
EE05179B1 (en) 2009-06-15
ES2215147T3 (en) 2004-10-01
BG66225B1 (en) 2012-06-29
HUP0301203A3 (en) 2006-05-29
HK1060566A1 (en) 2004-08-13
EP1382606A2 (en) 2004-01-21
EP1325001B1 (en) 2004-02-18
PL207311B1 (en) 2010-11-30
AU2002213975B2 (en) 2006-11-09
JP4109106B2 (en) 2008-07-02
UA73804C2 (en) 2005-09-15
KR100830359B1 (en) 2008-05-20
RS50464B (en) 2010-03-02
YU29503A (en) 2006-03-03
PE20020433A1 (en) 2002-06-28
NO20031693D0 (en) 2003-04-11
JP2008120834A (en) 2008-05-29
KR20030041165A (en) 2003-05-23
NO20031693L (en) 2003-05-28
HRP20030278B1 (en) 2006-02-28
MXPA03003160A (en) 2005-09-09
DK1325001T3 (en) 2004-06-21
NO328207B1 (en) 2010-01-11
EA200300459A1 (en) 2003-10-30
SK4352003A3 (en) 2003-08-05
EP1382606A3 (en) 2004-10-13
JP2004511557A (en) 2004-04-15
ECSP034542A (en) 2003-06-25
PL360673A1 (en) 2004-09-20
HUP0301203A2 (en) 2003-10-28
IL155334A0 (en) 2003-11-23
PT1325001E (en) 2004-07-30

Similar Documents

Publication Publication Date Title
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
CA2425560A1 (en) Anticholinergics, processes for preparing them and their use as pharmaceutical compositions
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
YU72002A (en) Benzoylpyrazols and their use as herbicides
TR200102800T2 (en) New compounds.
GB0003154D0 (en) Novel compounds
BG106013A (en) New compounds and compositions as protease inhibitors
BG103413A (en) Derivatives of sulphinic acid, their production and application
MY134582A (en) New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments
DE60214591D1 (en) Pyrazolpyrimidinfungizide
PL366198A1 (en) Novel compounds
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
MY133392A (en) Novel substituted pyrazole derivatives
AP2002002637A0 (en) Novel piperazine
MXPA04002067A (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments.
MXPA04000755A (en) Novel compounds.
MXPA04000577A (en) Dolastatin 10 derivatives.
MXPA02011370A (en) Substituted iminoazines.
IL158324A0 (en) Arylsulphonamides as anttiviral agents
MXPA04002282A (en) Novel compounds and compositions as cathepsin inhibitors.
SE0203070D0 (en) Novel compounds
SE0101038D0 (en) Novel compounds
BG105710A (en) 5ht1 antagonists for antidepressant therapy
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
CA2399377A1 (en) New positive allosteric ampa receptor modulators (paarm), processes for preparing them and their use as pharmaceutical compositions